礼新医药 is a biopharmaceutical company based in China that focuses on the research and development of innovative drugs in the fields of tumor immunotherapy and tumor microenvironment. It develops large molecule antibodies and antibody-drug conjugates, and has various projects advancing into clinical research.

礼新医药

LaNova Medicines | 164 followers on LinkedIn. Care for life. Dedicate to innovation. | Founded in 2019 in Shanghai, China, LaNova Medicines is a clinical-stage biotechnology company committed to the discovery and development of novel biologic drugs for cancer treatment.

Led by industry veterans with a strong passion for innovation, we aim to operate as an R&amp;D engine and deliver transformative medicines to address the unmet clinical needs of cancer patients. Leveraging our proprietary technology platforms and deep understanding of the tumor microenvironment. we have built a differentiated pipeline of products and are striving to progress our programs toward the clinic.

LaNova Medicines Ltd. - Chief Operating Officer

Jason Li

LaNova Medicines - Sr.Director of Discovery

Wentao Huang

Director, Medical Sciences

Da Fei

LaNova Medicines - Medical Science VP

Sherry Qin

LaNova Medicines

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 14, 2024 8:08 PM	da89cc73
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 14, 2024 8:08 PM	2bb3e08a
crunchbase trigger	general	Nov 14, 2024 8:08 PM	0e02946f
crunchbase profile	general
li profile	general	Nov 14, 2024 8:08 PM	2b796b00
translate crunchbase fundingrounds	general
peers	general	Nov 14, 2024 8:08 PM	c4e7e835
news basic	general	Nov 14, 2024 8:08 PM	57623228
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

LANO

COM:LANOVAMEDICINES

礼新医药